For the first time, the US Food and Drug Administration has approved the world’s first-ever cannabis-based medicine “Epidiolex” made from marijuana. It is a milestone approval that could spur more research into a drug that remains illegal under federal law. The drug, manufactured by UK-based GW Pharmaceuticals, will be used to cure children aged 2-years old, who suffer from Dravet Syndrome and Lennox-Gastaut Syndrome, rare childhood-onset forms of epilepsy. Epidiolex is a purified form of cannabidiol (CBD), one of the hundreds of molecules found in the marijuana plant. It contains less than 0.1% of Tetra-Hydro-Cannabinol (THC), which makes people high. In simple words, the new drug is an oral solution of cannabidiol (CBD) and does not cause intoxication or a high.